Canada markets closed

The Fight Against COVID19

The Fight Against COVID19

23.82k followers14 symbols Watchlist by TREA

Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.

Curated by TREA

TREA analyzes over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: FDA (Food and Drug Administration), NIH (National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2 among others.


WatchlistChange Today1 Month Return1 Year ReturnTotal Return
The Fight Against COVID19-1.11%---

14 Symbols

SymbolCompany NameLast PriceChange% ChangeMarket TimeVolumeAvg Vol (3 month)Market Cap
JNJJohnson & Johnson154.64+0.36+0.23%4:00 p.m. EDT6.09M7.46M372.17B
ABBVAbbVie Inc.166.42+2.07+1.26%4:00 p.m. EDT4.95M5.61M293.88B
PFEPfizer Inc.28.64-0.28-0.97%4:01 p.m. EDT25.66M42.47M162.29B
SNYSanofi48.67-0.15-0.31%4:00 p.m. EDT613.41k1.99M122.80B
REGNRegeneron Pharmaceuticals, Inc.982.29+14.31+1.48%4:00 p.m. EDT386.46k455.40k108.23B
GSKGSK plc44.98+0.10+0.22%4:00 p.m. EDT1.87M3.15M93.80B
GILDGilead Sciences, Inc.67.72-0.14-0.21%4:00 p.m. EDT3.57M6.97M84.37B
MRNAModerna, Inc.132.9+0.22+0.17%4:00 p.m. EDT2.70M3.82M50.93B
TAKTakeda Pharmaceutical Company Limited13.22-0.09-0.68%4:00 p.m. EDT1.01M1.65M41.70B
BNTXBioNTech SE90.61-2.37-2.55%4:00 p.m. EDT471.65k591.09k21.84B
NVAXNovavax, Inc.13.01-1.39-9.65%4:00 p.m. EDT13.76M12.78M1.92B
VIRVir Biotechnology, Inc.9.73-0.20-2.01%4:00 p.m. EDT624.61k988.40k1.32B
INOInovio Pharmaceuticals, Inc.12-0.79-6.18%4:00 p.m. EDT414.23k443.72k310.93M
  • Thomson Reuters StreetEvents

    Q1 2024 Autolus Therapeutics PLC Earnings Call

    Q1 2024 Autolus Therapeutics PLC Earnings Call

  • TipRanks

    Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?

    Moderna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again on the move — in a good way. The stock is up 68% over the past six months, with partnerships around artificial intelligence (AI) and positive cancer trial data garnering investor interest. Personally, though, I’m still unconvinced that these developments make MRNA stock a buy and require more data before I make a decision. For now, I remain neutral. MRNA stock has fallen significantly from its al

  • Simply Wall St.

    Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution

    The fact that multiple Johnson & Johnson ( NYSE:JNJ ) insiders offloaded a considerable amount of shares over the past...